Minocycline
Specifications
10118-90-8CAS Number
(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamideIUPAC Name
C23H27N3O7Chemical Formula
457.5 g/molMolecular Weight
minocycline; 10118-90-8; Minocyclin; Minociclina; Minomycin; Dynacin; Minocin; (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE; Minocyn; 7-Dimethylamino-6-demethyl-6-deoxytetracycline; CL 59806; DTXSID1045033; FYY3R43WGO; Tri-minocycline; (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide; 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; Minocyclinum; CHEBI:50694; NSC 141993; Minocyclinum [INN-Latin]; NCGC00183044-01; Borymycin; Minociclina [INN-Spanish]; MIY; MINO; minociclinum; Minocline; Minoz; Mino-Tabs; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-; HSDB 3130; NSC-141993; Minocin (Hydrochloride); Vectrin (Hydrochloride); UNII-FYY3R43WGO; Minocycline (USAN/INN); BRN 3077644; Lactoferrin B & Minocycline; Lactoferrin H & Minocycline; Minocycline [USAN:INN:BAN]; Minomycin;; SR-05000001675; (minocycline); Minoderm;; Aknemin;; Arestin;; Dynacin;; Minocin;; Sebomin;; Solodyn;; Akamin;; (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2- CARBOXAMIDE; (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide; NSC141993; Spectrum_000967; MINOCYCLINE [MI]; Prestwick0_000315; Prestwick1_000315; Prestwick2_000315; Spectrum2_001047; Spectrum3_000508; Spectrum4_000062; Spectrum5_001293; MINOCYCLINE [INN]; MINOCYCLINE [HSDB]; MINOCYCLINE [USAN]; MINOCYCLINE [VANDF]; SCHEMBL4042; CHEMBL1434; MINOCYCLINE [MART.]; SCHEMBL24315; BSPBio_002035; KBioGR_000583; KBioSS_001447; MINOCYCLINE [WHO-DD]; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,12aalpha))-; DivK1c_000450; SPBio_000974; SPBio_002529; orb1989822; DTXCID9025033; SCHEMBL16681149; SCHEMBL29369923; SCHEMBL29416350; BCBcMAP01_000027; GTPL10831; KBio1_000450; KBio2_001447; KBio2_004015; KBio2_006583; KBio3_001535; NINDS_000450; HMS2090D03; KUC106429N; (4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide;(4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide; 2-NAPHTHACENECARBOXAMIDE, 4,7-BIS(DIMETHYLAMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-, (4S-(4.ALPHA.,4A.ALPHA.,5A.ALPHA.,12A.ALPHA.))-; KSC-12-231B; Tox21_113643; BDBM50103599; EBC-27149; HY-17412A; LMPK07000002; AKOS015969674; CL59806; DB01017; Minocycline; Tigecycline EP Impurity C; IDI1_000450; SMP1_000191; NCGC00178854-01; NCGC00178854-02; NCGC00188954-01; NCGC00482890-01; AC-30184; CL-59806; DA-65471; SBI-0051449.P003; CAS-10118-90-8; CS-0009521; NS00007904; TIGECYCLINE IMPURITY C [EP IMPURITY]; C07225; D05045; D78303; AB00053501-03; AB00053501_04; AB00053501_05; EN300-7481098; Q415336; T131626; SR-05000001675-3; (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-Synonyms
Products Containing Minocycline
Companies Selling Minocycline
CT
Công ty cổ phần dược phẩm WealpharViet NamSP
STARWAY PHARM Co., Ltd.ChinaCT
Công ty TNHH dược phẩm Huy VănViet NamCT
Công ty cổ phần dược mỹ phẩm Bảo AnViet NamCT
Công ty cổ phần dược phẩm Phúc LongViet NamCT
Công ty TNHH Dược phẩm LamdaViet Nam